Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 50% – Still a Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s stock price traded up 50% during mid-day trading on Thursday . The company traded as high as C$0.11 and last traded at C$0.11. 1,942,446 shares changed hands during trading, an increase of 1,795% from the average session volume of 102,479 shares. The stock had previously closed at C$0.07.

Voyageur Pharmaceuticals Stock Performance

The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The stock has a market capitalization of C$14.64 million, a PE ratio of -10.50 and a beta of 0.32. The firm’s fifty day moving average is C$0.07 and its 200-day moving average is C$0.06.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Recommended Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.